Company intelligence

AVXL

Anavex Life Sciences Corp. · NASDAQ · Healthcare

Price$2.86+0.35% · +$0.01

Market cap265.04MEquity value

P / E-18.0Trailing ratio

Volume307.15KLatest session

Market data

AVXL price chart

TradingView

Related signals

1 min delayed

Browse public AVXL signals with their source context and measured market impact. Open any signal for its permanent analysis page.

AVXLMar 25, 2026-0.03% since signal

Anavex Faces EMA Setback, Shares Plummet to 52-Week Low

Anavex Life Sciences has faced a setback with the EMA denying a positive opinion for its lead drug blarcamesine. Following significant share price decline of over 32%, Anavex is now focused on gathering additional data to address EMA's concerns, which could influence future stock performance.

View signal analysis

AVXLDec 22, 2024+29.55% since signal

What To Expect in the Markets This Week

Markets close Wednesday for Christmas, affecting trading volumes. Anavex Life Sciences (AVXL) will report earnings on December 23. Consumer confidence data could influence market sentiment towards AVXL. Limited earnings reports may lead to increased focus on AVXL's performance. Economic indicators to be released could impact AVXL's market dynamics.

View signal analysis

Research